Franklin Shaffer, EdD, RN, FAAN, FFNMRCSI

Dr. Shaffer will provide a background of activities and initiatives surrounding 2020 The International Year of the Nurse and the Midwife. He then will explore the implications to nephrology nursing practice and predictions for the future, particularly in light of the challenges confronting health care this year.

Lisa Jennings, MSN, CCRN-CMC, ACNP-BC, CHFN, CVNP-BC, FHFSA

Treatment options for severe heart failure include left ventricular assist devices (LVADs) and extra-corporeal membrane oxygenation (ECMO). As nephrology nurses care for patients at risk for heart failure, it is important to understand the indications for the use of these devices and how they work. Learn more about the nursing care for patients with LVADs/ECMO and potential treatment complications.

Leah Foster Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF

This session will explore opportunities for advanced practice nurses to maximize their impact in various nephrology settings, including office-based clinics, outpatient dialysis, and acute care, in order to maximize reimbursement opportunities.

Aileen Ahiskali, PharmD, BCIDP

This session will focus on the impact and pattern of emerging infections – both bacterial and viral. Antibiotic resistance, implications for treatment and management, and vaccine development will be discussed.

Tyson Moore, APRN, FNP-C, CPN

This session will focus on current hot topics in pediatric nephrology care and issues surrounding the transition from pediatric to adult care for nephrology patients.

Mitch Rosner, MD, MACP

This session will include a discussion of the etiology, incidence, prevalence, and risk factors for acute kidney injury. The RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) and Acute Kidney Injury Network (AKIN) classifications, treatment options, and patient outcomes also will be reviewed.

Peter Hathaway, MD

Access devices continue to evolve, and this session will focus on newer access devices such as the HeRO® graft and percutaneous fistula. Discussion will address access placement, opportunities for earlier use in patients compared to other options, postoperative care, and access maintenance.

Michael Quadrini, MD

Sponsored by Amgen